Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2 : A pan India study

Copyright © 2021. Published by Elsevier B.V..

BACKGROUND: COVID-19 has posed unforeseen circumstances and throttled major economies worldwide. India has witnessed two waves affecting around 31 million people representing 16% of the cases globally. To date, the epidemic waves have not been comprehensively investigated to understand pandemic progress in India.

OBJECTIVE: Here, we aim for pan Indian cross-sectional evolutionary analysis since inception of SARS-CoV-2.

METHODS: High quality genomes, along with their collection date till 26th July 2021, were downloaded. Whole genome-based phylogeny was obtained. Further, the mutational analysis was performed using SARS-CoV-2 first reported from Wuhan (NC_045512.2) as reference.

RESULTS: Based on reported cases and mutation rates, we could divide the Indian epidemic into seven phases. The average mutation rate for the pre-first wave was <11, which elevated to 17 in the first wave and doubled in the second wave (∼34). In accordance with mutation rate, VOCs and VOIs started appearing in the first wave (1.5%), which dominated the second (∼96%) and post-second wave (100%). Nation-wide mutational analysis depicted >0.5 million mutation events with four major mutations in >19,300 genomes, including two mutations in coding (spike (D614G), and NSP 12b (P314L) of rdrp), one silent mutation (NSP3 F106F) and one extragenic mutation (5' UTR 241).

CONCLUSION: Whole genome-based phylogeny could demarcate post-first wave isolates from previous ones by point of diversification leading to incidences of VOCs and VOIs in India. Such analysis is crucial in the timely management of pandemic.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:308

Enthalten in:

Virus research - 308(2022) vom: 15. Jan., Seite 198642

Sprache:

Englisch

Beteiligte Personen:

Kumar, Sanjeet [VerfasserIn]
Bansal, Kanika [VerfasserIn]

Links:

Volltext

Themen:

5' Untranslated Regions
COVID-19
Deadly variants
Evolution
Genome-wide
Journal Article
Mutation
NSP
Non-synonymous
RNA dependent RNA polymerase
SARS-CoV-2
SNP
Silent mutation
Spike
Spike Glycoprotein, Coronavirus
Spike protein, SARS-CoV-2
UTR
VOC
VOI

Anmerkungen:

Date Completed 01.02.2022

Date Revised 21.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.virusres.2021.198642

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM333601114